Nanocarrier based active targeting strategies against erythrocytic stage of malaria

AR Bhide, DH Surve, AB Jindal - Journal of Controlled Release, 2023 - Elsevier
Abstract The Global Technical Strategy for Malaria 2016–2030 aims to achieve a 90%
reduction in malaria cases, and strategic planning and execution are crucial for …

Active migration and passive transport of malaria parasites

RG Douglas, R Amino, P Sinnis, F Frischknecht - Trends in parasitology, 2015 - cell.com
Malaria parasites undergo a complex life cycle between their hosts and vectors. During this
cycle the parasites invade different types of cells, migrate across barriers, and transfer from …

Structural and immunological principles leading to chemically synthesized, multiantigenic, multistage, minimal subunit-based vaccine development

ME Patarroyo, A Bermúdez, MA Patarroyo - Chemical reviews, 2011 - ACS Publications
Dedicated to the memory of Professors Henry G. Kunkel and Bruce Merrifield (Rockefeller
University, New York), who introduced us to the fascinating worlds of immunology and …

Novel approaches to identify protective malaria vaccine candidates

WN Chia, YS Goh, L Rénia - Frontiers in microbiology, 2014 - frontiersin.org
Efforts to develop vaccines against malaria have been the focus of substantial research
activities for decades. Several categories of candidate vaccines are currently being …

Plasmodium helical interspersed subtelomeric (PHIST) proteins, at the center of host cell remodeling

JD Warncke, I Vakonakis, HP Beck - Microbiology and Molecular …, 2016 - Am Soc Microbiol
During the asexual cycle, Plasmodium falciparum extensively remodels the human
erythrocyte to make it a suitable host cell. A large number of exported proteins facilitate this …

Anti-Apical-Membrane-Antigen-1 Antibody Is More Effective than Anti-42-Kilodalton-Merozoite-Surface-Protein-1 Antibody in Inhibiting Plasmodium falciparum …

K Miura, H Zhou, A Diouf, SE Moretz… - Clinical and Vaccine …, 2009 - Am Soc Microbiol
ABSTRACT Apical membrane antigen 1 (AMA1) and the 42-kDa merozoite surface protein 1
(MSP142) are leading malaria vaccine candidates. Several preclinical and clinical trials …

Plasmodium falciparum Blood Stage Antimalarial Vaccines: An Analysis of Ongoing Clinical Trials and New Perspectives Related to Synthetic Vaccines

DR Salamanca, M Gómez, A Camargo… - Frontiers in …, 2019 - frontiersin.org
Plasmodium falciparum malaria is a disease causing high morbidity and mortality rates
worldwide, mainly in sub-Saharan Africa. Candidates have been identified for vaccines …

Hotspots in Plasmodium and RBC Receptor-Ligand Interactions: Key Pieces for Inhibiting Malarial Parasite Invasion

MA Patarroyo, J Molina-Franky, M Gómez… - International Journal of …, 2020 - mdpi.com
Protein-protein interactions (IPP) play an essential role in practically all biological
processes, including those related to microorganism invasion of their host cells. It has been …

The origin and diversification of the merozoite surface protein 3 (msp3) multi-gene family in Plasmodium vivax and related parasites

BL Rice, MM Acosta, MA Pacheco, JM Carlton… - Molecular phylogenetics …, 2014 - Elsevier
The genus Plasmodium is a diversified group of parasites with more than 200 known
species that includes those causing malaria in humans. These parasites use numerous …

Plasmodium vivax ligand-receptor interaction: PvAMA-1 domain I contains the minimal regions for specific interaction with CD71+ reticulocytes

G Arévalo-Pinzón, M Bermúdez, D Hernández… - Scientific reports, 2017 - nature.com
The malarial parasite's invasion is complex, active and coordinated, involving many low and
high affinity interactions with receptors on target cell membrane. Proteomics analysis has …